The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Investment of cash into trust account | 0 |
| Net cash used in investing activities | 0 |
| Net income | 11,891,655 |
| Prepaid expenses and other current assets | -121,586 |
| Due from sponsor | 5,254 |
| Long-term prepaid insurance | -61,667 |
| Accrued expenses | 1,694 |
| Interest earned on marketable securities held in trust account | 12,443,573 |
| Net cash used in operating activities | -372,225 |
| Proceeds from sale of units, net of underwriting discounts paid | 0 |
| Proceeds from sale of private placements warrants | 0 |
| Proceeds from promissory note - related party | 0 |
| Repayment of promissory note - related party | 0 |
| Payment of offering costs | 0 |
| Advances from related party | 1,313 |
| Net cash provided by financing activities | 1,313 |
| Net change in cash | -370,912 |
| Cash beginning of the period | 483,572 |
| Cash end of the period | 112,660 |
GP-Act III Acquisition Corp. (GPAT)
GP-Act III Acquisition Corp. (GPAT)